Treatment intensification strategies for men undergoing definitive radiotherapy for high-risk prostate cancer
ConclusionTreatment intensification using a combination of EBRT, advanced hormonal therapies, and brachytherapy may improve patient outcomes and survival in men with high-risk prostate cancer. Shared decision-making between patients and multidisciplinary teams of radiation oncologists, urologists, and medical oncologists is essential for personalizing care in this setting and deciding which strategies make sense for individual patients.
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research
More News: Abiraterone Acetate | Brachytherapy | Cancer | Cancer & Oncology | External Beam Therapy | Hormones | Prostate Cancer | Toxicology | Urology & Nephrology